Master blanket purchase agreement for pharmaceutical supplies.

Ended Blanket Purchase Agreement Awarded Last action

Contract number
HT001421A0014
Awardee
Awarding agency
Task orders
30 $1,431,413 obligated

Award facts

Opportunity
  • HT001421RFI01 Solicitation number
Combined order value
$1,431,413 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 22% used
$6,500,000.00
Maximum order
$250,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

The Defense Health Agency awarded a blanket purchase agreement indefinite-delivery/indefinite-quantity contract to Sofie CO, doing business as Sofie, with a potential value of $6.5 million. Task orders issued against the contract by the Agency call for Sofie to provide various radiopharmaceuticals and pharmaceutical products to support the Agency's medical treatment facilities and programs. Delivery locations include Sterling, Virginia and Bethesda, Maryland. The orders specify needs for customized radiopharmaceutical doses and injections for prostate cancer patients, as well as generic pharmaceuticals and cancer medications. The contracts utilize firm-fixed-price and fixed-price task orders, include periods of performance from 2021 through 2023, and were awarded without any set-aside designations. As the healthcare component of the Department of Defense, the Defense Health Agency relies on contracts such as these to ready and sustain the medical supply chain in support of its global health mission for military service members and other eligible beneficiaries.

The task orders indicate the Defense Health Agency's need for specialized radiopharmaceuticals and pharmaceuticals to maintain diagnostic imaging services, cancer treatment capabilities, and overall patient care at its medical facilities. Sofie CO and its parent company Sofie Biosciences appear positioned to fulfill these highly specific product requirements through the base blanket purchase agreement and subsequent task order awards, collectively valued at millions, without use of set-asides. The orders showcase how the Agency leverages pre-competed contracts to streamline acquisition of crucial medical commodities ensuring military readiness and quality care for all beneficiaries.

Task orders

Task order Ordering agency Obligated Awarded
Radiopharmaceutical required for patient care. HT009024FG0810071 Defense Health Agency $10,826
Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definitive treatment HT009024FG0510058 Defense Health Agency $32,478
Radiopharmaceutical needed for patient care. HT009023FG0910085 Defense Health Agency $32,478
Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definitive treatement HT009023FG0810066 Defense Health Agency $14,435
Pharmaceuticals. HT009023FG0710051 Defense Health Agency $14,435
Radiopharmaceutical needed for prostate cancer patient with metastic lesions after definitive treatment. HT009023FG0610056 Defense Health Agency $14,435
Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definitive treatment. HT009023FG0410054 Defense Health Agency $32,478
Pharmaceuticals. HT009023FG0310058 Defense Health Agency $21,652
Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definitive treatment HT009023FG0210050 Defense Health Agency $43,305
Radiopharmaceuticals. HT009023FG0110045 Defense Health Agency $20,976
Radiophamaceutical needed for prostate cancer patient with metastatic lesions after definitive treatment. HT009023FG1210051 Defense Health Agency $20,976
Pharmaceutical supplies. HT009023FG1110049 Defense Health Agency $27,968
PYL-c pylarify F18 piflufolastat injecti HT001423F0017 Defense Health Agency $246,665
Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definitive treatment. HT009023FG1010082 Defense Health Agency $34,960
Radiotherapeutic pharmaceutical. HT009022FG0910097 Defense Health Agency $45,448
Radiopharmaceuticals. HT009022FG0870091 Defense Health Agency $48,944
PYL-c pylarify F18 piflufolastat injections HT001422F0120 Defense Health Agency $249,463
Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definitive treatment HT009022FG710049 Defense Health Agency $20,973
Radiopharmaceuticals needed for prostate cancer patient with metastatic lesions after definitive treatment HT009022FG710048 Defense Health Agency $24,472
Pharmaceutical needed for patient care. HT009022FG0610048 Defense Health Agency $27,968
Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definitive treatment HT009022FG0510016 Defense Health Agency $20,976
Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definitive treatment HT009022FG0510017 Defense Health Agency $13,984
Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definitive treatment. HT009022FG4A00029 Defense Health Agency $17,480
Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definitive treatment HT009022FG0310026 Defense Health Agency $17,568
Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definitive treatment HT009022FG0310027 Defense Health Agency $10,541
Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definitive treatment HT009022FG0210025 Defense Health Agency $18,368
Radiopharmaceutical doses (X4). HT009022FG0110021 Defense Health Agency $13,984
Acquisition of medication for cancer treatment. HT001422F0003 Defense Health Agency $231,792
This is a BPA call against BPA master HT001421A0014 with sofie CO. For pylarify 71258-022-01 and pitflufolastat F18. HT001421F0197 Defense Health Agency $87,400
Pylarify dose- radiotherapeutic pharmaceutical HT009021FG0910055 Defense Health Agency $13,984
Show all 30

Quick answers

Who was awarded contract HT001421A0014?

HT001421A0014 was awarded to Sofie CO. by Defense Health Agency (Department of Defense) on July 28, 2021.

How much is contract HT001421A0014 worth?

Orders under HT001421A0014 have obligated $1,431,413. HT001421A0014's own ceiling is $6,500,000. A single order can be worth up to $250,000.

How many orders have been placed under contract HT001421A0014?

30 orders have been placed under HT001421A0014, the latest on August 13, 2024.

Who can order from contract HT001421A0014?

HT001421A0014 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV